Tenecteplase Is a Better Alternative to Alteplase for Patients With Large Vessel Occlusion Stroke Receiving Bridging Therapy

Neurology. 2024 Jul;103(1):e209581. doi: 10.1212/WNL.0000000000209581. Epub 2024 Jun 12.

Authors

Shlee S Song¹, Steven Warach¹

Affiliation

¹ From the Department of Neurology (S.S.S.), Cedars Sinai Medical Center, Los Angeles, CA; and Department of Neurology (S.W.), Seton Dell Medical School Stroke Institute, Austin, TX.

PMID: 38865680
DOI: 10.1212/WNL.0000000000209581

No abstract available

Publication types

Editorial
Comment

MeSH terms

Fibrinolytic Agents* / therapeutic use
Humans
Ischemic Stroke / drug therapy
Stroke / drug therapy
Tenecteplase* / therapeutic use
Tissue Plasminogen Activator* / therapeutic use
Treatment Outcome

Substances

Tissue Plasminogen Activator
Tenecteplase
Fibrinolytic Agents